Global Ophthalmology Disorders Drug Professional Survey Report 2022, Forecast to 2027

Table of Contents

Global Ophthalmology Disorders Drug Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Ophthalmology Disorders Drug Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Ophthalmology Disorders Drug Segment by Type
2.1.1 Oral
2.1.2 Injection
2.1.3 External Use
2.2 Market Analysis by Application
2.2.1 Juvenile Macular Degeneration (Stargardt Disease)
2.2.2 Leber Congenital Amaurosis (LCA)
2.2.3 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
2.2.4 Usher Syndrome
2.2.5 Retinitis Pigmentosa (Retinitis)
2.3 Global Ophthalmology Disorders Drug Market Comparison by Regions (2017-2027)
2.3.1 Global Ophthalmology Disorders Drug Market Size (2017-2027)
2.3.2 North America Ophthalmology Disorders Drug Status and Prospect (2017-2027)
2.3.3 Europe Ophthalmology Disorders Drug Status and Prospect (2017-2027)
2.3.4 Asia-pacific Ophthalmology Disorders Drug Status and Prospect (2017-2027)
2.3.5 South America Ophthalmology Disorders Drug Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Ophthalmology Disorders Drug Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Ophthalmology Disorders Drug Industry Impact
2.5.1 Ophthalmology Disorders Drug Business Impact Assessment - Covid-19
2.5.2 Market Trends and Ophthalmology Disorders Drug Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Ophthalmology Disorders Drug Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Ophthalmology Disorders Drug Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Ophthalmology Disorders Drug Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Ophthalmology Disorders Drug Manufacturer Market Share
3.5 Top 10 Ophthalmology Disorders Drug Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Ophthalmology Disorders Drug Market
3.7 Key Manufacturers Ophthalmology Disorders Drug Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Ophthalmology Disorders Drug Industry Key Manufacturers
4.1 Sanofi
4.1.1 Company Details
4.1.2 Sanofi Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.1.3 Sanofi Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Sanofi News
4.2 Pfizer
4.2.1 Company Details
4.2.2 Pfizer Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.2.3 Pfizer Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 Novartis
4.3.1 Company Details
4.3.2 Novartis Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.3.3 Novartis Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Novartis News
4.4 Bayer
4.4.1 Company Details
4.4.2 Bayer Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.4.3 Bayer Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Bayer News
4.5 Roche
4.5.1 Company Details
4.5.2 Roche Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.5.3 Roche Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Roche News
4.6 Bausch + Lomb
4.6.1 Company Details
4.6.2 Bausch + Lomb Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.6.3 Bausch + Lomb Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Bausch + Lomb News
4.7 Gilead Sciences
4.7.1 Company Details
4.7.2 Gilead Sciences Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.7.3 Gilead Sciences Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Gilead Sciences News
4.8 Takeda Pharmaceutical
4.8.1 Company Details
4.8.2 Takeda Pharmaceutical Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.8.3 Takeda Pharmaceutical Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Takeda Pharmaceutical News
4.9 Usher Syndrome
4.9.1 Company Details
4.9.2 Usher Syndrome Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.9.3 Usher Syndrome Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Usher Syndrome News
4.10 Allergan
4.10.1 Company Details
4.10.2 Allergan Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.10.3 Allergan Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Allergan News
4.11 Amgen Inc
4.11.1 Company Details
4.11.2 Amgen Inc Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.11.3 Amgen Inc Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Amgen Inc News
4.12 ReNeuron
4.12.1 Company Details
4.12.2 ReNeuron Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.12.3 ReNeuron Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 ReNeuron News
4.13 Kubota Pharmaceutical
4.13.1 Company Details
4.13.2 Kubota Pharmaceutical Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.13.3 Kubota Pharmaceutical Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Kubota Pharmaceutical News
4.14 Ocugen
4.14.1 Company Details
4.14.2 Ocugen Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.14.3 Ocugen Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Ocugen News
4.15 Editas Medicine Inc
4.15.1 Company Details
4.15.2 Editas Medicine Inc Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.15.3 Editas Medicine Inc Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Editas Medicine Inc News
4.16 Ferrer Corporate
4.16.1 Company Details
4.16.2 Ferrer Corporate Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.16.3 Ferrer Corporate Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Ferrer Corporate News
4.17 Alkeus Pharmaceuticals
4.17.1 Company Details
4.17.2 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.17.3 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Alkeus Pharmaceuticals News
4.18 Amarantus BioScience
4.18.1 Company Details
4.18.2 Amarantus BioScience Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.18.3 Amarantus BioScience Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Amarantus BioScience News
4.19 ProQR Therapeutics NV
4.19.1 Company Details
4.19.2 ProQR Therapeutics NV Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.19.3 ProQR Therapeutics NV Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 ProQR Therapeutics NV News
4.20 Astellas Pharma
4.20.1 Company Details
4.20.2 Astellas Pharma Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.20.3 Astellas Pharma Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 Astellas Pharma News
4.21 Stealth BioTherapeutics
4.21.1 Company Details
4.21.2 Stealth BioTherapeutics Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.21.3 Stealth BioTherapeutics Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.21.4 Main Business Overview
4.21.5 Stealth BioTherapeutics News
4.22 ReGenX Biosciences
4.22.1 Company Details
4.22.2 ReGenX Biosciences Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.22.3 ReGenX Biosciences Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.22.4 Main Business Overview
4.22.5 ReGenX Biosciences News
4.23 Acucela
4.23.1 Company Details
4.23.2 Acucela Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.23.3 Acucela Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.23.4 Main Business Overview
4.23.5 Acucela News
4.24 Second Sight Medical
4.24.1 Company Details
4.24.2 Second Sight Medical Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.24.3 Second Sight Medical Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.24.4 Main Business Overview
4.24.5 Second Sight Medical News
4.25 AmpliPhi Biosciences
4.25.1 Company Details
4.25.2 AmpliPhi Biosciences Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.25.3 AmpliPhi Biosciences Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.25.4 Main Business Overview
4.25.5 AmpliPhi Biosciences News
4.26 Okuvision
4.26.1 Company Details
4.26.2 Okuvision Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.26.3 Okuvision Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.26.4 Main Business Overview
4.26.5 Okuvision News
4.27 Applied Genetic Technologies
4.27.1 Company Details
4.27.2 Applied Genetic Technologies Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.27.3 Applied Genetic Technologies Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.27.4 Main Business Overview
4.27.5 Applied Genetic Technologies News
4.28 Sucampo Pharmaceuticals
4.28.1 Company Details
4.28.2 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.28.3 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.28.4 Main Business Overview
4.28.5 Sucampo Pharmaceuticals News
4.29 Sun Pharma Advanced Research Company
4.29.1 Company Details
4.29.2 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.29.3 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.29.4 Main Business Overview
4.29.5 Sun Pharma Advanced Research Company News
4.30 Orphagen Pharmaceuticals
4.30.1 Company Details
4.30.2 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Product Introduction, Application and Specification
4.30.3 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.30.4 Main Business Overview
4.30.5 Orphagen Pharmaceuticals News

5 Global Ophthalmology Disorders Drug Sales Categorized by Regions
5.1 Global Ophthalmology Disorders Drug Revenue, Sales and Market Share by Regions
5.1.1 Global Ophthalmology Disorders Drug Sales and Market Share by Regions (2017-2022)
5.1.2 Global Ophthalmology Disorders Drug Revenue and Market Share by Regions (2017-2022)
5.2 North America Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
5.3 Europe Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
5.5 South America Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)

6 North America Ophthalmology Disorders Drug Market Size Categorized by Countries
6.1 North America Ophthalmology Disorders Drug Sales, Revenue and Market Share by Countries
6.1.1 North America Ophthalmology Disorders Drug Sales (Volume) by Countries (2017-2022)
6.1.2 North America Ophthalmology Disorders Drug Revenue by Countries (2017-2022)
6.1.3 United States Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
6.1.4 Canada Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
6.1.5 Mexico Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
6.2 North America Ophthalmology Disorders Drug Revenue (Value) by Manufacturers
6.3 North America Ophthalmology Disorders Drug Sales and Market Share by Type (2017-2022)
6.4 North America Ophthalmology Disorders Drug Sales Market Share by Application (2017-2022)

7 Europe Ophthalmology Disorders Drug Market Size Categorized by Countries
7.1 Europe Ophthalmology Disorders Drug Sales, Revenue and Market Share by Countries
7.1.1 Europe Ophthalmology Disorders Drug Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Ophthalmology Disorders Drug Revenue by Countries (2017-2022)
7.1.3 Germany Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
7.1.4 UK Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
7.1.5 France Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
7.1.6 Russia Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
7.1.7 Italy Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
7.1.8 Spain Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
7.2 Europe Ophthalmology Disorders Drug Revenue (Value) by Manufacturers
7.3 Europe Ophthalmology Disorders Drug Sales and Market Share by Type (2017-2022)
7.4 Europe Ophthalmology Disorders Drug Sales Market Share by Application (2017-2022)

8 Asia-Pacific Ophthalmology Disorders Drug Market Size Categorized by Countries
8.1 Asia-pacific Ophthalmology Disorders Drug Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Ophthalmology Disorders Drug Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Ophthalmology Disorders Drug Revenue by Countries (2017-2022)
8.1.3 China Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
8.1.4 South Korea Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
8.1.5 Japan Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
8.1.6 Australia Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
8.1.7 India Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Ophthalmology Disorders Drug Revenue (Value) by Manufacturers
8.3 Asia-pacific Ophthalmology Disorders Drug Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Ophthalmology Disorders Drug Sales Market Share by Application (2017-2022)

9 South America Ophthalmology Disorders Drug Market Size Categorized by Countries
9.1 South America Ophthalmology Disorders Drug Sales, Revenue and Market Share by Countries
9.1.1 South America Ophthalmology Disorders Drug Sales (Volume) by Countries (2017-2022)
9.1.2 South America Ophthalmology Disorders Drug Revenue by Countries (2017-2022)
9.1.3 Brazil Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
9.2 South America Ophthalmology Disorders Drug Sales and Market Share by Type (2017-2022)
9.3 South America Ophthalmology Disorders Drug Sales Market Share by Application (2017-2022)

10 Middle East and Africa Ophthalmology Disorders Drug Market Size Categorized by Countries
10.1 Middle East and Africa Ophthalmology Disorders Drug Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Ophthalmology Disorders Drug Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Ophthalmology Disorders Drug Revenue by Countries (2017-2022)
10.1.3 GCC Countries Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
10.1.4 Turkey Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
10.1.5 Egypt Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
10.1.6 South America Ophthalmology Disorders Drug Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Ophthalmology Disorders Drug Sales and Market Share by Type
10.3 Middle East and Africa Ophthalmology Disorders Drug Sales Market Share by Application (2017-2022)

11 Global Ophthalmology Disorders Drug Market Segment by Type
11.1 Global Ophthalmology Disorders Drug Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Ophthalmology Disorders Drug Sales and Market Share by Type (2017-2022)
11.1.2 Global Ophthalmology Disorders Drug Revenue and Market Share by Type (2017-2022)
11.2 Oral Sales Growth Rate and Price
11.2.1 Global Oral Sales Growth Rate (2017-2022)
11.2.2 Global Oral Price (2017-2022)
11.3 Injection Sales Growth Rate and Price
11.3.1 Global Injection Sales Growth Rate (2017-2022)
11.3.2 Global Injection Price (2017-2022)
11.4 External Use Sales Growth Rate and Price
11.4.1 Global External Use Sales Growth Rate (2017-2022)
11.4.2 Global External Use Price (2017-2022)

12 Global Ophthalmology Disorders Drug Market Segment by Application
12.1 Global Ophthalmology Disorders Drug Sales Market Share by Application (2017-2022)
12.2 Juvenile Macular Degeneration (Stargardt Disease) Sales Growth Rate (2017-2022)
12.3 Leber Congenital Amaurosis (LCA) Sales Growth Rate (2017-2022)
12.4 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate (2017-2022)
12.5 Usher Syndrome Sales Growth Rate (2017-2022)

13 Global Ophthalmology Disorders Drug Market Forecast
13.1 Global Ophthalmology Disorders Drug Revenue, Sales and Growth Rate (2022-2027)
13.2 Ophthalmology Disorders Drug Market Forecast by Regions (2022-2027)
13.2.1 North America Ophthalmology Disorders Drug Market Forecast (2022-2027)
13.2.2 Europe Ophthalmology Disorders Drug Market Forecast (2022-2027)
13.2.3 Asia-Pacific Ophthalmology Disorders Drug Market Forecast (2022-2027)
13.2.4 South America Ophthalmology Disorders Drug Market Forecast (2022-2027)
13.2.5 Middle East & Africa Ophthalmology Disorders Drug Market Forecast (2022-2027)
13.3 Ophthalmology Disorders Drug Market Forecast by Type (2022-2027)
13.3.1 Global Ophthalmology Disorders Drug Sales Forecast by Type (2022-2027)
13.3.2 Global Ophthalmology Disorders Drug Market Share Forecast by Type (2022-2027)
13.4 Ophthalmology Disorders Drug Market Forecast by Application (2022-2027)
13.4.1 Global Ophthalmology Disorders Drug Sales Forecast by Application (2022-2027)
13.4.2 Global Ophthalmology Disorders Drug Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Ophthalmology Disorders Drug Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Ophthalmology Disorders Drug Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers



List of Tables and Figures

Figure Product Picture Ophthalmology Disorders Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Ophthalmology Disorders Drug
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Ophthalmology Disorders Drug Market Size by Type
Figure Global Market Share of Ophthalmology Disorders Drug by Type in 2021
Figure Oral Picture
Figure Injection Picture
Figure External Use Picture
Table Global Ophthalmology Disorders Drug Market Size (Volume) by Application
Figure Juvenile Macular Degeneration (Stargardt Disease) Picture
Figure Leber Congenital Amaurosis (LCA) Picture
Figure Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Picture
Figure Usher Syndrome Picture
Figure Retinitis Pigmentosa (Retinitis) Picture
Table Global Ophthalmology Disorders Drug Comparison by Regions (M USD) 2017-2027
Figure Global Ophthalmology Disorders Drug Market Size (Million US$) (2017-2027)
Figure North America Ophthalmology Disorders Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Ophthalmology Disorders Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Ophthalmology Disorders Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Ophthalmology Disorders Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Ophthalmology Disorders Drug Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Ophthalmology Disorders Drug Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Ophthalmology Disorders Drug Sales by Manufacturer (2017-2022)
Figure Global Ophthalmology Disorders Drug Sales Market Share by Manufacturer in 2021
Table Global Ophthalmology Disorders Drug Revenue by Manufacturer (2017-2022)
Figure Global Ophthalmology Disorders Drug Revenue Market Share by Manufacturer in 2021
Table Global Ophthalmology Disorders Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Ophthalmology Disorders Drug Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Ophthalmology Disorders Drug Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Ophthalmology Disorders Drug Market
Table Key Manufacturers Ophthalmology Disorders Drug Product Type
Table Mergers & Acquisitions Planning
Table Sanofi Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Sanofi
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Table Pfizer Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Pfizer
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Novartis Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Novartis
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Bayer Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Bayer
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table Roche Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Roche
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Bausch + Lomb Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Bausch + Lomb
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bausch + Lomb 2017-2022
Table Bausch + Lomb Main Business
Table Bausch + Lomb Recent Development
Table Gilead Sciences Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Gilead Sciences
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Gilead Sciences 2017-2022
Table Gilead Sciences Main Business
Table Gilead Sciences Recent Development
Table Takeda Pharmaceutical Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Takeda Pharmaceutical
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Takeda Pharmaceutical 2017-2022
Table Takeda Pharmaceutical Main Business
Table Takeda Pharmaceutical Recent Development
Table Usher Syndrome Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Usher Syndrome
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Usher Syndrome 2017-2022
Table Usher Syndrome Main Business
Table Usher Syndrome Recent Development
Table Allergan Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Allergan
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Allergan 2017-2022
Table Allergan Main Business
Table Allergan Recent Development
Table Amgen Inc Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Amgen Inc
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amgen Inc 2017-2022
Table Amgen Inc Main Business
Table Amgen Inc Recent Development
Table ReNeuron Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of ReNeuron
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ReNeuron 2017-2022
Table ReNeuron Main Business
Table ReNeuron Recent Development
Table Kubota Pharmaceutical Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Kubota Pharmaceutical
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Kubota Pharmaceutical 2017-2022
Table Kubota Pharmaceutical Main Business
Table Kubota Pharmaceutical Recent Development
Table Ocugen Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Ocugen
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ocugen 2017-2022
Table Ocugen Main Business
Table Ocugen Recent Development
Table Editas Medicine Inc Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Editas Medicine Inc
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Editas Medicine Inc 2017-2022
Table Editas Medicine Inc Main Business
Table Editas Medicine Inc Recent Development
Table Ferrer Corporate Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Ferrer Corporate
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ferrer Corporate 2017-2022
Table Ferrer Corporate Main Business
Table Ferrer Corporate Recent Development
Table Alkeus Pharmaceuticals Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Alkeus Pharmaceuticals
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Alkeus Pharmaceuticals 2017-2022
Table Alkeus Pharmaceuticals Main Business
Table Alkeus Pharmaceuticals Recent Development
Table Amarantus BioScience Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Amarantus BioScience
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amarantus BioScience 2017-2022
Table Amarantus BioScience Main Business
Table Amarantus BioScience Recent Development
Table ProQR Therapeutics NV Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of ProQR Therapeutics NV
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ProQR Therapeutics NV 2017-2022
Table ProQR Therapeutics NV Main Business
Table ProQR Therapeutics NV Recent Development
Table Astellas Pharma Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Astellas Pharma
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Astellas Pharma 2017-2022
Table Astellas Pharma Main Business
Table Astellas Pharma Recent Development
Table Stealth BioTherapeutics Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Stealth BioTherapeutics
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Stealth BioTherapeutics 2017-2022
Table Stealth BioTherapeutics Main Business
Table Stealth BioTherapeutics Recent Development
Table ReGenX Biosciences Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of ReGenX Biosciences
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ReGenX Biosciences 2017-2022
Table ReGenX Biosciences Main Business
Table ReGenX Biosciences Recent Development
Table Acucela Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Acucela
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Acucela 2017-2022
Table Acucela Main Business
Table Acucela Recent Development
Table Second Sight Medical Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Second Sight Medical
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Second Sight Medical 2017-2022
Table Second Sight Medical Main Business
Table Second Sight Medical Recent Development
Table AmpliPhi Biosciences Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of AmpliPhi Biosciences
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AmpliPhi Biosciences 2017-2022
Table AmpliPhi Biosciences Main Business
Table AmpliPhi Biosciences Recent Development
Table Okuvision Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Okuvision
Table Ophthalmology Disorders Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Okuvision 2017-2022
Table Okuvision Main Business
Table Okuvision Recent Development
Table Applied Genetic Technologies Company Profile
Table Ophthalmology Disorders Drug Product Introduction, Application and Specification of Applied Genetic Technologies
Table Ophthalmology Diso

Sanofi
Pfizer
Novartis
Bayer
Roche
Bausch + Lomb
Gilead Sciences
Takeda Pharmaceutical
Usher Syndrome
Allergan
Amgen Inc
ReNeuron
Kubota Pharmaceutical
Ocugen
Editas Medicine Inc
Ferrer Corporate
Alkeus Pharmaceuticals
Amarantus BioScience
ProQR Therapeutics NV
Astellas Pharma
Stealth BioTherapeutics
ReGenX Biosciences
Acucela
Second Sight Medical
AmpliPhi Biosciences
Okuvision
Applied Genetic Technologies
Sucampo Pharmaceuticals
Sun Pharma Advanced Research Company
Orphagen Pharmaceuticals